erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Nourse JG and Roberts JD Nuclear magnetic resonance spectroscopy. Carbon-13 spectra of some macrolide antibiotics and derivatives. Substituent and conformational effects. 1975 J. Am. Chem. Soc. pmid:1159223
Kashimura M et al. Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs. 2001 J. Antibiot. pmid:11592503
Okazaki N et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. 2001 Microbiol. Immunol. pmid:11592636
Buitendijk SE [Erythromycin for premature rupture of membranes is beneficial for infant]. 2001 Ned Tijdschr Geneeskd pmid:11593784
Culasso C et al. [Streptococcus pneumoniae: evolution of antibiotic resistance in a pediatric hospital in Córdoba, Argentina]. 2001 Jul-Sep Rev. Argent. Microbiol. pmid:11594005
Buitendijk SE Antibiotics in preterm labour. 2001 Lancet pmid:11597708
Singer JI and DeVoe WM Severe Mycoplasma pneumoniae infection in otherwise healthy siblings. 1979 J. Pediatr. pmid:115983
Cave VG The management of the several stages of syphilis. 1975 J Natl Med Assoc pmid:1159858
Hsueh PR et al. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. 2001 Antimicrob. Agents Chemother. pmid:11600380
Nagai K et al. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. 2001 Antimicrob. Agents Chemother. pmid:11600391
Okamoto H et al. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae. 2001 Antimicrob. Agents Chemother. pmid:11600393
Haas CE et al. Effects of metronidazole on hepatic CYP3A4 activity. 2001 Pharmacotherapy pmid:11601665
Nishino T An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus. 1975 Jpn. J. Microbiol. pmid:1160202
Polli JW et al. Rational use of in vitro P-glycoprotein assays in drug discovery. 2001 J. Pharmacol. Exp. Ther. pmid:11602674
Bolton WK et al. Ventriculojugular shunt nephritis with Corynebacterium bovis. Successful therapy with antibiotics. 1975 Am. J. Med. pmid:1163549
Boek-Dohalská L et al. alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6. 2001 Chem. Biol. Interact. pmid:11640917
Costalos C et al. The effect of low-dose erythromycin on whole gastrointestinal transit time of preterm infants. 2001 Early Hum. Dev. pmid:11641030
Marchandin H et al. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France. 2001 Pathol. Biol. pmid:11642013
Maugein J et al. [In vitro activity of pristinamycin against Streptococcus pneumoniae]. 2001 Pathol. Biol. pmid:11642023
Chuma T et al. Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999. 2001 J. Vet. Med. Sci. pmid:11642273
McCapes RH et al. Injecting antibiotics into turkey hatching eggs to eliminate Mycoplasma meleagridis infection. 1975 Jul-Sep Avian Dis. pmid:1164318
Dans PE Treatment of Gonorrhea and syphilis: Part II--syphilis. 1975 South. Med. J. pmid:1166341
Gray JE Drug-induced enteropathy characterized by lipid in macrophages. 1975 Vet. Pathol. pmid:1166589
Faas H et al. Pressure-geometry relationship in the antroduodenal region in humans. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11668030
Rasmussen JE Toxic epidermal necrolysis. A review of 75 cases in children. 1975 Arch Dermatol pmid:1167045
Chiou WL et al. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. 2001 Clin. Pharmacol. Ther. pmid:11673745
Rivory LP and Watkins PB Erythromycin breath test. 2001 Clin. Pharmacol. Ther. pmid:11673756
Pantosti A et al. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy. 2001 Clin. Microbiol. Infect. pmid:11678935
Ohwada S et al. Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. 2001 Ann. Surg. pmid:11685031
Dubois J and St-Pierre C In vitro susceptibility study of BMS-284756 against Legionella species. 2001 Sep-Oct Diagn. Microbiol. Infect. Dis. pmid:11687318
Bravo F et al. Synthesis of erythro and threo furanoid glycals from 1- and 2-phenylselenenyl-carbohydrate derivatives. 2001 Carbohydr. Res. pmid:11689179
Carreras C et al. Saccharopolyspora erythraea-catalyzed bioconversion of 6-deoxyerythronolide B analogs for production of novel erythromycins. 2002 J. Biotechnol. pmid:11689246
Niwa H et al. Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay. 2001 Int. J. Antimicrob. Agents pmid:11691569
Gorrini M et al. Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11694455
Manning SD et al. Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students. 2001 Clin. Infect. Dis. pmid:11698992
Dreno B et al. Erythromycin-resistance of cutaneous bacterial flora in acne. 2001 Nov-Dec Eur J Dermatol pmid:11701406
Lobene RR Clinical studies of plaque control agents: an overview. 1979 J. Dent. Res. pmid:117032
Gonorrhea: recommended treatment schedules-1974. Part II: Disseminated gonococcal infection and gonococcal infection in pediatric patients. 1975 Obstet Gynecol pmid:1170528
Koh TW Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration. 2001 Pacing Clin Electrophysiol pmid:11707056
Snow JC et al. Corneal injuries during general anesthesia. 1975 Jul-Aug Anesth. Analg. pmid:1170781
Bührer C et al. Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum. 2001 Drugs pmid:11708762
Tanikawa T et al. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics. 2001 J. Med. Chem. pmid:11708904
Ma Z et al. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. 2001 J. Med. Chem. pmid:11708916
Teng LJ et al. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. 2001 Antimicrob. Agents Chemother. pmid:11709309
de Azavedo JC et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. 2001 Antimicrob. Agents Chemother. pmid:11709331
Neuhauser MM et al. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. 2001 Antimicrob. Agents Chemother. pmid:11709352
Singh KV et al. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. 2001 Antimicrob. Agents Chemother. pmid:11709359
von Kobyletzki G et al. [Acute generalized cat scratch disease in myelodysplastic syndrome]. 2001 Hautarzt pmid:11715399
Ye Y et al. [Clinic intervention study on urogenital mycoplasma infection of pregnant women]. 2001 Zhonghua Liu Xing Bing Xue Za Zhi pmid:11718071
Schmidt LE et al. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. 2001 Clin. Pharmacol. Ther. pmid:11719731